MedPath

Neuromodulation and Dynamic Balance in Stroke

Not Applicable
Recruiting
Conditions
Stroke
Interventions
Device: Sham
Device: Portable Neuromodulation Stimulation
Other: Gait and balance training
Registration Number
NCT05135533
Lead Sponsor
Medical University of South Carolina
Brief Summary

Portable Neuromodulation Stimulator (PoNS) is non-invasive stimulation device placed on the tongue to stimulate those brain regions understood to be important for maintaining balance. This research study aims to collect evidence that PoNS therapy along with balance training improves postural and walking stability post-stroke.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • At least six months since the onset of Ischemic or hemorrhagic stroke.
  • Demonstrate residual paresis in the lower extremity (Fugl-Mayer lower extremity score < 34).
  • Are able to provide informed consent demonstrated by their ability to weigh the consequences of participating versus not participating in the study.
  • Can walk at least 10 feet with and without assistive device.
  • Functional Gait Assessment score <22.
Exclusion Criteria
  • Pre-existing neurological disorders.
  • Previous stroke affecting the other hemisphere .
  • Severe arthritis or orthopedic problems that limit passive range of motion.
  • Areas of recent bleeding or open wounds.
  • Lack normal sensation on the tongue.
  • Received treatment for cancer within the past year.
  • Non-removable metal orthodontic devices.
  • Oral health problems.
  • Are sensitive to nickel, gold or copper.
  • Chronic infectious diseases.
  • Are pregnant.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ShamSham-
Portable Neuromodulation StimulatorGait and balance training-
Portable Neuromodulation StimulatorPortable Neuromodulation Stimulation-
ShamGait and balance training-
Primary Outcome Measures
NameTimeMethod
Change in gait speedPre-treatment, midpoint at four weeks, and post-treatment at 12 weeks

Self-selected comfortable walking overground walking speed.

Change in balancePre-treatment, midpoint at four weeks, and post-treatment at at 12 weeks

Functional Gait Assessment (FGA) assesses stability during walking. The score ranges between 0 and 30 with lower scores indicative of poor dynamic balance.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Medical University of South Carolina

🇺🇸

Charleston, South Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath